ETFis Series Trust I. Holdings as of Jul 31, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| CRINETICS PHARMACEUTICALS INC | 3.34% | $3.29M | 39,373 |
| KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | 1.97% | $1.94M | 26,155 |
| VERASTEM INCVSTM | 1.95% | $1.92M | 331,013 |
| PRECIGEN INCPGEN | 1.94% | $1.91M | 304,977 |
| OMEROS CORPOMER | 1.87% | $1.84M | 155,369 |
| NUVATION BIO INCNUVB | 1.77% | $1.75M | 275,843 |
| REGENERON PHARMACEUTICALSREGN | 1.72% | $1.69M | 2,218 |
| PROTAGONIST THERAPEUTICS INCPTGX | 1.71% | $1.69M | 12,363 |
| ACADIA PHARMACEUTICALS INCACAD | 1.69% | $1.66M | 64,350 |
| BRIDGEBIO PHARMA INCBBIO | 1.65% | $1.63M | 20,315 |
| BEONE MEDICINES LTDONC | 1.65% | $1.62M | 5,132 |
| XERIS BIOPHARMA HOLDINGS INCXERS | 1.64% | $1.61M | 199,875 |
| HALOZYME THERAPEUTICS INCHALO | 1.64% | $1.61M | 19,528 |
| LIQUIDIA CORPLQDA | 1.63% | $1.60M | 19,053 |
| IMMUNOCORE HOLDINGS PLCIMCR | 1.61% | $1.58M | 46,863 |
| IRONWOOD PHARMACEUTICALS INCIRWD | 1.60% | $1.57M | 371,823 |
| ARROWHEAD PHARMACEUTICALS INCARWR | 1.56% | $1.54M | 18,212 |
| ROIVANT SCIENCES LTD | 1.55% | $1.53M | 45,179 |
| LIGAND PHARMACEUTICALSLGND | 1.55% | $1.53M | 5,310 |
| RHYTHM PHARMACEUTICALS INCRYTM | 1.55% | $1.52M | 15,357 |
| GERON CORPGERN | 1.54% | $1.52M | 1,180,129 |
| RIGEL PHARMACEUTICALS INCRIGL | 1.54% | $1.52M | 41,313 |
| ASCENDIS PHARMA A/S | 1.54% | $1.52M | 6,224 |
| ARCUTIS BIOTHERAPEUTICS INCARQT | 1.52% | $1.50M | 55,666 |
| INCYTE CORPINCY | 1.52% | $1.49M | 12,506 |
| CYTOKINETICS INCCYTK | 1.51% | $1.49M | 19,346 |
| MODERNA INCMRNA | 1.51% | $1.49M | 27,191 |
| AMGEN INCAMGN | 1.49% | $1.47M | 3,820 |
| TRAVERE THERAPEUTICS INCTVTX | 1.48% | $1.46M | 26,078 |
| KRYSTAL BIOTECH INCKRYS | 1.48% | $1.46M | 4,269 |
| VERTEX PHARMACEUTICALS INCVRTX | 1.48% | $1.46M | 3,052 |
| BIOMARIN PHARMACEUTICAL INCBMRN | 1.48% | $1.46M | 24,255 |
| ZAI LAB LTDZLAB | 1.47% | $1.45M | 79,505 |
| MIRUM PHARMACEUTICALS INCMIRM | 1.47% | $1.45M | 13,661 |
| DENALI THERAPEUTICS INCDNLI | 1.46% | $1.44M | 62,658 |
| TG THERAPEUTICS INCTGTX | 1.45% | $1.43M | 27,407 |
| NEUROCRINE BIOSCIENCES INCNBIX | 1.44% | $1.42M | 8,494 |
| SYNDAX PHARMACEUTICALS INCSNDX | 1.44% | $1.42M | 74,364 |
| GILEAD SCIENCES INCGILD | 1.43% | $1.41M | 10,807 |
| BIOCRYST PHARMACEUTICALS INCBCRX | 1.42% | $1.40M | 155,993 |
| ADMA BIOLOGICS INCADMA | 1.42% | $1.40M | 165,305 |
| ULTRAGENYX PHARMACEUTICAL INRARE | 1.41% | $1.39M | 55,734 |
| HARMONY BIOSCIENCES HOLDINGS INCHRMY | 1.41% | $1.39M | 39,383 |
| AGIOS PHARMACEUTICALS INCAGIO | 1.40% | $1.38M | 46,067 |
| BIOGEN INCBIIB | 1.40% | $1.38M | 6,785 |
| THERAVANCE BIOPHARMA INC | 1.40% | $1.38M | 81,560 |
| IMMUNITYBIO INCIBRX | 1.39% | $1.37M | 191,148 |
| INSMED INCINSM | 1.39% | $1.37M | 13,870 |
| BIONTECH SEBNTX | 1.38% | $1.36M | 14,989 |
| EXELIXIS INCEXEL | 1.37% | $1.35M | 25,544 |
Holdings from the fund's latest Form N-PORT; expense ratio (net of fee waivers) from the risk/return summary of its prospectus; fund type from Form N-CEN. Prices are end-of-day closes adjusted for splits; total return also reinvests distributions.